Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors

Clinical trial NCT07647068 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07647068
Sponsor: Joal Beane
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastrointestinal Stromal Tumor Metastatic Gastrointestinal Stromal Tumor Recurrent Gastrointestinal Stromal Tumor Refractory Malignant Gastrointestinal Stromal Tumor Unresectable Malignant Gastrointestinal Stromal Tumor

Start date: 2026-08-15
Primary completion: 2027-12-31
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.